A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore

This publication has 29 references indexed in Scilit:

• Regulatory Loophole Enables Unproven Autologous Cell Therapies to Thrive in Australia
  Stem Cells and Development, 2014
• Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines
  Law, Innovation and Technology, 2014
• The Global Landscape of Stem Cell Clinical Trials
  Regenerative Medicine, 2013
• Injectable Cultured Bone Marrow–Derived Mesenchymal Stem Cells in Varus Knees With Cartilage Defects Undergoing High Tibial Osteotomy: A Prospective, Randomized Controlled Clinical Trial With 2 Years' Follow‐up
  Arthroscopy, 2013
• Responsible research and innovation: The role of privacy in an emerging framework
  Science and Public Policy, 2013
• Pay-to-Participate Funding Schemes in Human Cell and Tissue Clinical Studies
  Regenerative Medicine, 2012
• Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine
  British Medical Bulletin, 2011
• Autologous Bone Marrow–Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation
  The American Journal of Sports Medicine, 2010
• Medicine on the Fringe: Stem Cell-Based Interventions in Advance of Evidence
  Stem Cells, 2009
• Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine
  Cell Stem Cell, 2008